LISA SCHMIDT: Open Payments
NPI 1508862202 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$725 in 19 payments from 12 companies in 2025. Trend: 2023 $861 · 2024 $772 · 2025 $725
Food & beverage: $725
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $173 |
| Abbott Laboratories | 3 | $162 |
| Medtronic, Inc. | 2 | $111 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $58 |
| ABBVIE INC. | 2 | $48 |
| Averitas Pharma Inc. | 1 | $44 |
| Valinor Pharma, LLC | 2 | $37 |
| SI-BONE, INC. | 1 | $23 |
| SPR Therapeutics, Inc | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
Products named: Intracept, PROCLAIM, INTELLIS ADAPTIVESTIM, JOURNAVX, QUTENZA, MOVANTIK, BOTOX, QULIPTA.
Industry payments across IN — which companies pay providers there.
